The usefulness of a free self-test for screening albuminuria in the general population: A cross-sectional survey

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Nielen, Markus Mj ^a   Schellevis, François G ^a,b   Verheij, Robert A ^a  

^a NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL EVALUATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; E-MAIL; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEALTH CARE; HUMAN; HYPERTENSION; INTERNET; KIDNEY; MALE; NON PROFIT ORGANIZATION; POPULATION; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; SCREENING; SELF EVALUATION; SOCIAL SUPPORT; TREATMENT OUTCOME;

DIABETES MELLITUS; HUMANS; SOCIAL SUPPORT; TREATMENT OUTCOME;

EID: 70449441716     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-381     Document Type: Article

References (13)

1. Global and societal implications of the diabetes epidemic. P Zimmet KG Alberti J Shaw, Nature 2001 414 782 787 10.1038/414782a 11742409
2. Global burden of hypertension: analysis of worldwide data. PM Kearney M Whelton K Reynolds P Muntner PK Whelton J He, Lancet 2005 365 217 223 15652604
3. Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. CA Johnson AS Levey J Coresh A Levin J Lau G Eknoyan, Am Fam Physician 2004 70 869 876 15368726 (Pubitemid 39201438)
4. Dutch Kidney Foundation, the Netherland, http://www.professional. nierstichting.nl (18 May 2009)
5. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. AS Go GM Chertow D Fan CE McCulloch CY Hsu, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656
6. Proteinuria and the risk of developing end-stage renal disease. K Iseki Y Ikemiya C Iseki S Takishita, Kidney Int 2003 63 1468 1474 10.1046/j.1523-1755. 2003.00868.x 12631363 (Pubitemid 36350012)
7. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. I Giatras J Lau AS Levey, Ann Intern Med 1997 127 337 345 9273824
8. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. JC Peterson S Adler JM Burkart T Greene LA Hebert LG Hunsicker AJ King S Klahr SG Massry JL Seifter, Ann Intern Med 1995 123 754 762 7574193
9. Principles and practice of screening for disease. JMG Wilson G Jungner, Genève: WHO 1968
10. Range of self-tests available to buy in the United Kingdom: an Internet survey. A Ryan S Wilson S Greenfield S Clifford RJ McManus HM Pattison, J Public Health (Oxf) 2006 28 370 374 10.1093/pubmed/fdl051 17052990
11. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). AS Levey KU Eckardt Y Tsukamoto A Levin J Coresh J Rossert D De Zeeuw TH Hostetter N Lameire G Eknoyan, Kidney Int 2005 67 2089 2100 10.1111/j.1523-1755.2005.00365.x 15882252
12. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. AX Garg BA Kiberd WF Clark RB Haynes CM Clase, Kidney Int 2002 61 2165 2175 10.1046/j.1523-1755.2002.00356.x 12028457
13. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. N Halbesma DS Kuiken AH Brantsma SJ Bakker JF Wetzels D De Zeeuw PE De Jong RT Gansevoort, J Am Soc Nephrol 2006 17 2582 2590 10.1681/ASN.2005121352 16899519